drugset / Trial / NCT06053567
Community-based Smoking Cessation Treatment for Adults With High Stress Sensitivity.
Phase 3
Recruiting
360 enrolled
Jasper A. Smits
National Cancer Institute (NCI) · collabUniversity of Houston · collabUniversity of Oklahoma · collabYMCA · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
Anxiety sensitivity, reflecting the fear of bodily sensations, is a risk factor for the maintenance and relapse of smoking. This study is designed to address the question - is a smoking cessation intervention personalized to high anxiety sensitive smokers and adapted for implementation by the YMCA effective among racially/ethnically diverse samples?
Timeline
- Start
- 2023-12-27
- Primary completion
- 2029-03-31
- Completion
- 2029-06-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Background | Nicotine | Unknown | — | Other |